Subcutaneously administered repronex® in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment

John E. Nichols, Eric Knochenhauer, Seymour Fein, Ronald V. Nardi, Dennis C. Marshall
In: Fertility and Sterility · 2001 · vol. 76(1) , pp. 58–66 · doi:10.1016/s0015-0282(01)01856-8 · PMID:11438320 · W1679507718
article OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Subcutaneous repronex® administration in oligoovulatory females undergoing ovulation induction demonstrated comparable efficacy and tolerability to intramuscular human menopausal gonadotropin treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

References (36)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T06:22:51.059792+00:00
License: CC0 · commercial use OK